1. 1321 Efficacy and safety of trabectedin (T) or dacarbazine (D) in an elderly patient subgroup (65 years) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) after prior chemotherapy. (September 2015) Authors: Von Mehren, M.; Demetri, G.D.; Schuetze, S.M.; Jones, R.L.; Milhem, M.; Elias, A.; Van Tine, B.A.; Hamm, J.; Khokhar, N.Z.; McCarthy, S.; Park, Y.C.; Knoblauch, R.E.; Parekh, T.V.; Maki, R.G.; Patel, S.R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3403 Final overall survival (OS) analysis of the randomized phase 3 study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS). (September 2015) Authors: Patel, S.; Mehren, M. Von; Reed, D.; Agulnik, M.; Kaiser, P.; Charlson, J.; Kraft, A.; Hamm, J.; Karnad, A.; Ryan, C.; Rushing, D.; Meyer, C.; Khokhar, N.Z.; McCarthy, S.; Park, Y.C.; Knoblauch, R.E.; Parekh, T.V.; Maki, R.G.; Demetri, G.D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3436 Efficacy and safety of trabectedin (T) or dacarbazine (D) for treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS) after prior chemotherapy. (September 2015) Authors: Demetri, G.; Patel, S.R.; Thomas, S.; Livingston, M.; Undevia, S.D.; Richardson, G.; Singh, A.S.; Seth, R.; Forscher, C.; Hinshaw, I.; Hussein, A.; D'Amato, G.; Chawla, S.; Khokhar, N.Z.; Park, Y.C.; Knoblauch, R.E.; Parekh, T.V.; Maki, R.G.; Mehren, M. Von Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 364 A summary score to assess toxicity of small molecule oral kinase inhibitors (SMOKIs) in randomized clinical trials (RCTs). (September 2015) Authors: Carbini, M.; Maki, R.G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Corrigendum to "SELNET clinical practice guidelines for bone sarcoma" Critical reviews in oncology/hematology, vol. 174 (2022), 1–10. (December 2022) Authors: Blay, J.Y.; Palmerini, E.; Bollard, J.; Aguiar, S.; Angel, M.; Araya, B.; Badilla, R.; Bernabeu, D.; Campos, F.; Chs, Caro-Sánchez; Carvajal Montoya, A.; Casavilca-Zambrano, S.; Castro-Oliden, ; Chacón, M.; Clara-Altamirano, M.A.; Collini, P.; Correa Genoroso, R.; Costa, F.D.; Cuellar, M.; Dei To... Journal: Critical reviews in oncology/hematology Issue: Volume 180(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery. Issue 12 (August 2015) Authors: Joensuu, H.; Martin-Broto, J.; Nishida, T.; Reichardt, P.; Schöffski, P.; Maki, R.G. Journal: European journal of cancer Issue: Volume 51:Issue 12(2015:Aug.) Page Start: 1611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study. Issue 6 (June 2019) Authors: Fiocco, M.; Dijkstra, P.D.S.; Van der Wal, R.J.P.; Daolio, P.A.; Picci, P.; Gronchi, A.; Ferrari, S.; Özger, H.; Maki, R.G.; Schreuder, H.W.B.; Van der Geest, I.C.M.; Bramer, J.A.M.; Mastboom, W.J.B.; Boffano, M.; Goldenitsch, E.; Campanacci, D.; Cuomo, P.; Ferguson, P.C.; Griffin, A.M.; Sun, Y. Journal: Lancet oncology Issue: Volume 20:Issue 6(2019) Page Start: 877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗